Analysis of clinicopathological, tumor cell proliferation and apoptosis parameters in adenocarcinoma of the gastric cardia;Estudo clínico-patológico, da proliferação celular e da apoptose no adenocarcinoma gástrico da cárdia

Arquivos de Gastroenterologia

Volumn 43, Issue 3, 2006, Pages 184-190

  Mader, Ana Maria Amaral Antonio ^a,b   Patrício, Francy Reis Da Silva ^a   Rigueiro, Moacyr Pezati ^a   Lourenço, Laercio Gomes ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

Adenocarcinoma; Apoptosis; Cardia; Cell proliferation; Stomach neoplasms

Indexed keywords

BIOTIN; EOSIN; HEMATOXYLIN; PEROXIDASE; STREPTAVIDIN;

ADULT; APOPTOSIS; ARTICLE; CANCER STAGING; CARDIA CARCINOMA; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HELICOBACTER PYLORI; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MALE; PROGNOSIS; STOMACH ADENOCARCINOMA; SURVIVAL; TUMOR CELL;

EID: 33845580675     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032006000300006     Document Type: Article

References (40)

1. Bruno L, Nesi G, Montinaro F, Carassale G, Lassig R, Boddi V, Bechi P; Cortesini C. Clinicopathologic findings and results of surgical treatment in cardiac adenocarcinoma. J Surg Oncol. 2000;74:33-5.
2. Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, Risch HA, Perez-Perez GI, Schoenberg JB, Stanford JL, Rotterdam H, West AB, Fraumeni JF. An inverse relation between CagA+ strains of H. pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res. 1998;58:588-90.
3. Demirkan NC, Tuncyürek, Ertan EU, Alkanat MB, Icöz G. Correlation of histological classifications of carcinomas with location and prognosis. Gastroenterol Clin Biol. 2002;26:610-5.
4. Dicken BJ, Saunders LD, Jhangri GS, de Gara C, Cass C, Andrews S, Hamilton SM. Gastric cancer: establishing predictors of biologic behavior with use of population-based data. Ann Surg Oncol. 2004;11:629-35.
5. Driessen A, Van Raemdonck D, De Leyn P, Filez L, Peeters M, Winnepenninckx V, Penninckx F, Lerut T, Ectors N, HP Belgian Contact Group. Are carcinomas of the cardia oesophageal or gastric adenocarcinomas? Eur J Cancer. 2003;39:2487-94.
6. Elpek GO, Gelen T, Aksoy NH, Karpuzoglu T, Keles N. Microvessel count, proliferating cell nuclear antigen and Ki-67 indices in gastric adenocarcinoma. Pathol Oncol Res. 2000;6:59-64.
7. Erturk MS, Cicek Y, Ersan Y, Saribeyoglu K, Dogusoy G, Erginoz E. Analysis of clinicopathological prognostic parameters in adenocarcinoma of the gastric cardia. Acta Chir Belg. 2003;103:611-5.
8. Forones NM, Carvalho AP, Giannotti-Filho O, Lourenço LG, Oshima CT. Cell proliferation and apoptosis in gastric cancer and intestinal metaplasia. Arq Gastroenterol. 2005;42:30-4.
9. Goldblum JR. The significance and etiology of intestinal metaplasia of the esophagogastric junction. Ann Diagn Pathol. 2002;6:67-73.
10. Ikeguchi M, Cai J, Yamane N, Maeta M, Kaibara N. Clinical significance of spontaneous apoptosis in advanced gastric adenocarcinoma. Cancer. 1999;85:2329-35.
11. Instituto Nacional do Câncer - INCA. Estimativas da incidência da mortalidade por câncer no Brasil. Rio de Janeiro; 2005.
12. Isobe N, Onodera H, Mori A, Shimada Y, Yang W, Yasuda S, Fujimoto A, Ooe H, Arii S, Kitaichi M, Imamura M. Caspase-3 expression in human gastric carcinoma and its clinical significance. Oncology. 2004;66:201-9.
13. Jakl RJ, Miholic J, Koller R, Markis E, Wolner E. Prognostic factors in adenocarcinoma of the cardia. Am J Surg. 1995;169:316-20.
14. Jesionek-Kupnicka D, Tenderenda M, Rutkowski P. Extent of spontaneous apoptosis in gastric cancer: relation to proliferative index, p53 expression, CD34 expression and histopathological features. J Exp Clin Cancer Res. 2002;21:371-5.
15. Kassab P, Malheiros CA. Câncer da cárdia. In: Gama-Rodrigues JJ, Lopasso FP, Del Grande JC, Safatle NF, Bresciani C, Malheiros CA, editores. Câncer do estômago. Aspectos atuais do diagnóstico e tratamento. São Paulo: Andrei; 2002. p.241-51.
16. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239-57.
17. Kim JP, Kim YW, Yang HK, Noh DY. Significant prognostic factors by multivariate analysis of 3926 gastric cancer patients. World J Surg. 1994;18:872-7.
18. Koshida Y, Saegusa M, Okayasu I. Apoptosis, cell proliferation and expression of Bcl-2 and Bax in gastric carcinomas: immunohistochemical and clinicopathological study. Br J Cancer. 1997;75:367-73.
19. Lardenoye LW, Kappetein P, Lagaay MB, Allema JH, Breslau PJ. Survival of proximal third gastric carcinoma. J Surg Oncol. 1998;68:183-6.
20. Lee HK, Lee HS, Yang HK, Kim WH, Lee KU, Choe KJ, Kim JP. Prognostic significance of Bcl-2 and p53 expression in gastric cancer. Int J Colorectal Dis. 2003;18:518-25.
21. Lipponen P, Papinaho S, Eskelinen M, Klemi PJ, Aaltomaa S, Kosma VM, Marin S, Syrjänen K. DNA ploidy, S-phase fraction and mitotic indices as prognostic predictors of female breast cancer. Anticancer Res. 1992;12:1533-8.
22. Maeda K, Chung YS, Onoda N, Kato Y, Nitta A, Arimoto Y, Yamada N, Kondo Y, Sowa M. Proliferating cell nuclear antigen labeling index of preoperative biopsy specimens in gastric carcinoma with special reference to prognosis. Cancer. 1994;73:528-33.
23. Maeda K, Chung YS, Takatsuka S, Ogawa Y, Onoda N, Sawada T, Kato Y, Nitta A, Arimoto Y, Kondo Y. Tumor angiogenesis and tumor cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer. 1995;72:319-23.
24. Mangham DC, Rowlands DC, Newbold KM, Reynolds GM, Fielding JW, Hallissey MT. Expression of proliferating cell nuclear antigen (PCNA) in gastric carcinoma: no evidence for prognostic value. J Clin Pathol. 1994;47:473-4.
25. Noda S, Soejima K, Inokuchi K. Clinicopathological analysis of the intestinal type and diffuse type of gastric carcinoma. Jpn J Surg. 1980;10:277-83.
26. Papachristou DN, Agnanti N, D'Agostino H, Fortner JG. Histologically positive esophageal margin in the surgical treatment of gastric cancer. Am J Surg. 1980;139:711-3.
27. Plummer M, Franceschi S, Munoz N. Epidemiology of gastric cancer. IARC Sci Publ. 2004;157:311-26.
28. Rasbridge SA, Gillett CE, Seymour AM, Patel K, Richards MA, Rubens RD, Millis RR. The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma. Br J Cancer. 1994;70:335-41.
29. Saito H, Tsujitani S, Kondo A, Ikeguchi M, Maeta M, Kaibara N. Expression of vascular endothelial growth factor correlates with hematogenous recurrence in gastric carcinoma. Surgery. 1999;125:195-201.
30. Setälä LP, Kosma VM, Marin S, Lipponen PK, Eskelinen MJ, Syrjänen KJ, Alhava EM. Prognostic factors in gastric cancer: the value of vascular invasion, mitotic rate and lymphoplasmacytic infiltration. Br J Cancer. 1996;74:766-72.
31. Siewert JR, Stein HJ. Carcinoma of the cardia: carcinoma of the gastroesophageal junction - classification, pathology and extent of resection. Dis Esophagus. 1996;9:173-82.
32. Siewert JR, Feith M, Stein HJ. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol. 2005;90:139-46.
33. Sinicrope FA, Hart J, Hsu H, Lemoine M, Michelassi F, Stephens LC. Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas. Clin Cancer Res. 1999;5:1793-804.
34. Shinohara T, Ohshima K, Murayama H, Kikuchi M, Yamashita Y, Shirakusa T. Apoptosis and proliferation in gastric carcinoma: the association with histological type. Histopathology. 1996;29:123-9.
35. Tenderenda M, Rutkowski P, Jesionek-Kupnicka D, Kubiak R. Expression of CD34 in gastric cancer and its correlation with histology, stage, proliferation activity, p53 expression and apoptotic index. Pathol Oncol Res. 2001;7:129-34.
36. Terry MB, Gaudet MM, Gammon MD. The epidemiology of gastric cancer. Semin Radiat Oncol. 2002;12:111-27.
37. Törmänen U, Eerola AK, Rainio P, Vähäkangas K, Soini Y, Sormunen R, Bloigu R, Lehto VP, Pääkkö P. Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma. Cancer Res. 1995;55:5595-602.
38. Tsugane S. Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci. 2005;96:1-6.
39. Zheng HC, Sun JM, Wei ZL, Yang XF, Zhang YC, Xin Y. Expression of Fas ligand and caspase-3 contributes to formation of immune escape in gastric cancer. World J Gastroenterol. 2003;9:1415-20.
40. Yamasaki F, Tokunaga O, Sugimori H. Apoptotic index in ovarian carcinoma: correlation with clinicopathologic factors and prognosis. Gynecol Oncol. 1997;66:439-48.